阿斯特拉加索酸IV通过调节NLRP3炎症酶来改善糖尿病病
Han Zhu1, Liping Zheng1, Keqin Zhao2
1Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Journal of diabetes research
|December 9, 2025
概括
阿斯特拉加索酸IV通过向NLRP3炎症酶激活来治疗糖尿病病 (DKD) 是有前途的. 这种天然化合物为管理DKD进展及其并发症提供了一种新的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 自然产品 化学 化学
背景情况:
- 糖尿病病 (DKD) 是全球末期病的主要原因,目前的治疗方法产生不理想的结果.
- 由NLRP3炎症酶驱动的无菌性炎症是DKD病变的关键因素.
- 由于其多样化的生物活性,天然产品为新药发现提供了丰富的来源.
研究的目的:
- 审查阿斯特拉加洛酸IV (AS-IV) 改善DKD的机制.
- 探索AS-IV在DKD中调节NLRP3炎症酶激活中的作用.
- 突出AS-IV作为DKD的潜在治疗剂.
主要方法:
- 文献综述侧重于研究AS-IV和DKD的研究.
- 分析AS-IV对关键的DKD通路的影响,包括炎症,氧化应激,内质网膜应激,脂质代谢和热.
- 检查AS-IV对NLRP3炎症酶激活的影响.
主要成果:
- AS-IV在延缓DKD进展方面表现出多方面的治疗效果.
- AS-IV有效调节NLRP3炎症酶激活,减少炎症.
- AS-IV表现出抗炎,抗氧化,内分泌网膜减轻压力,调节脂质新陈代谢和抑制热的特性.
结论:
- AS-IV 是一个有前途的天然产品,用于治疗DKD.
- 通过AS-IV准NLRP3炎症酶激活,为DKD提供了一个新的治疗策略.
- 对AS-IV的进一步研究可能会导致糖尿病病的新药开发.
更多相关视频
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
2.2K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
843
相关概念视频
01:23Dipeptidyl Peptidase 4 Inhibitors
559
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
559
01:24Glucagon-like Receptor Agonists
820
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
820
01:28Chronic Kidney Disease III: Interprofessional Care
323
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
323
01:24Nephrotic Syndrome III : Nursing Management
271
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
271
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
244
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
244
01:26Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184